Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)

Market Cap	2.29B -12.3%
Revenue (ttm)	650.83M +0.4%
Net Income	37.07M -1.2%
EPS	0.11 -1.2%
Shares Out	330.95M
PE Ratio	62.51
Forward PE	n/a
Dividend	0.08 (1.15%)
Ex-Dividend Date	May 29, 2026

Volume	4,032,200
Open	6.98
Previous Close	7.00
Day's Range	6.89 - 7.05
52-Week Range	5.76 - 9.68
Beta	0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 27, 2026

About SHE:002566

Jilin Jian Yisheng Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, wholesale, retail, import, and export of pharmaceutical products in China. The company offers drugs comprising capsules, injections, tablets, granules, and other drug products; cosmetics; ginseng products; bee products; and food products comprising acai collagen solid drinks, multivitamin mineral tablets, collagen peptide juice drinks, and fruit lemon powder. It is also involved in pharmaceutical contract manufacturing;...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1997
• Employees: 1,656
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002566

Financial Performance

In 2025, SHE:002566's revenue was 640.17 million, a decrease of -4.23% compared to the previous year's 668.47 million. Earnings were 29.00 million, a decrease of -44.32%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 14, 2026

Data Sources Report a data error